Chen Yuwei, She Yongbo, Kaur Ramandeep, Guo Na, Zhang Xiaohua, Zhang Ruisan, Gou Xingchun
Shaanxi Key Laboratory of Brain Disorders, Department of Public Health, Xi'an Medical University.
Department of Food and Human Nutritional Sciences, The University of Manitoba.
J Oleo Sci. 2019 Sep 4;68(9):811-816. doi: 10.5650/jos.ess19116. Epub 2019 Aug 14.
Cardiovascular disease (CVD) has emerged as the leading cause of dealth worldwide today. Lowering circulating total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) is one of the most effective approaches of CVD prevention. Dietary guidelines and health organizations approved using plant sterols (PS) as the alternative to conventional method in attenuating circulating TC and LDL-C levels and risk of CVD. However, current findings apprear to be controversial on the efficacy of PS. Giving the rise of the field "Nutrigenetics", single nucleotide polymorphisms (SNPs) such as CYP7A1-rs3808607 have been identified that strongly associate with cholesterol metabolism in response to PS intake, towards causing inter-individual variations. This review article aims to discuss the efficacy of dietary PS in managing cholesterol levels based on findings from recent studies. The scope includes reviewing evidence on supporting the efficacy, the metabolic claims, inter-individual variations as well as sitosterolemia associated with PS intake.
心血管疾病(CVD)已成为当今全球首要死因。降低循环总胆固醇(TC)和低密度脂蛋白胆固醇(LDL-C)是预防心血管疾病最有效的方法之一。饮食指南和健康组织认可使用植物甾醇(PS)作为传统方法的替代手段,以降低循环TC和LDL-C水平及心血管疾病风险。然而,目前关于植物甾醇功效的研究结果似乎存在争议。随着“营养遗传学”领域的兴起,已发现单核苷酸多态性(SNP),如CYP7A1-rs3808607,与摄入植物甾醇后胆固醇代谢密切相关,从而导致个体间差异。这篇综述文章旨在根据近期研究结果讨论膳食植物甾醇在控制胆固醇水平方面的功效。范围包括审查支持其功效的证据、代谢声称、个体间差异以及与摄入植物甾醇相关的谷甾醇血症。